T HE key finding in this interesting article by Hotta and colleagues, "Age-Related Adipose Tissue mRNA Expression of ADDlISREBPl, PPARy, Lipoprotein Lipase, and GLUT4 Glucose Transporter in Rhesus Monkeys" (pp. B 183-B188), is that aging is associated with declines in expression of certain transcription factors that regulate preadipocyte differentiation and fat cell function in whole fat tissue from rhesus monkeys. A cascade of transcription factors regulates differentiation of preadipocytes into fat cells. Continuing expression of some of these factors is also required to maintain the adipose phenotype in fat cells. Signals, including glucocorticoids, insulin, nutrient availability, and cytokines, among others, activate these transcription factor pathways. Hormones and paracrine factors also modulate expression of these transcription factors in fat cells. An example is TNFa, which is produced in fat tissue and reduces expression of both PPAR-yand ClEBPa (1-5). The hormone and paracrine factor milieu of fat tissue changes with age. The amount of TNFa produced in fat tissue increases with age (6) . Hence, changes in transcription factor expression seen in this study could result from aging changes intrinsic to adipose cells or could be a secondary result of changes in hormonal and paracrine milieu with age.
Only a third or so of cells in whole fat tissue are fat cells. The remaining cells are stromal-vascular cells, which include preadipocytes, macrophages,monocytes, mesothelial cells, and others. The proportions of these cell types change with aging (7) (8) (9) . Changes with age in whole fat tissue mRNA levels can therefore reflect changes in the abundance of these cell types. Certain non-adipose cell types in whole fat tissue contain some of the same transcription factors as fat cells and preadipocytes. Macrophages and monocytes are known to express PPAR-yand CIEBP's (10-12). To complicate matters further, mRNA levels do not fully reflect the functional activities of the transcription factors that control preadipocyte differentiation and fat cell function. Many of these transcription factors are regulated post-transcriptionally. For example, cytokines blunt PPAR-yfunctional activity both by affecting its mRNA levels and by inducing phosphorylation through MAP kinase pathways (13, 14) . Efficient binding ofPPAR-y to DNA requires the presence of another differentiation-dependent transcription factor, RXRa (15) . This could change with age. Furthermore, PPAR-yis a ligand-activated transcription factor. As yet unknown endogenous ligands are generated, in part, through SREBP-lc (16) . This protein needs to be activated by cleavage from a membrane-bound precursor. The amount of activated protein may not be predicted entirely from mRNA levels. Activated SREBP-lc protein then appears to alter the regulation of genes that result in production of endogenous ligands, which act in an autocrine fashion. How aging affects SREBP-lc cleavage, or other pathways that result in generation of endogenous ligands, is not known. TNFa and IL-6 are produced by adipose cells and also act in an autocrine fashion (1, 17) . These autocrine pathways may be affected not only by the ratio of preadipocytes to fat cells and of adipose to non-adipose cell types in fat tissue, but also by hormones, For example, glucocorticoids inhibit IL-6 release by adipose tissue (17) . All of these variables that influence transcription factor mRNA levels could change with age, and the relevance of changes in mRNA levels needs to be tested at the level of functional activity.
Despite the difficulties inherent in interpreting what aging does in fat cells by looking at transcription factor mRNA levels in whole fat tissue influenced by the animals' hormonal state, several interesting conclusions can be drawn from this study, as pointed out by the authors. First, their work in whole tissue lends support to our observation that adipogenic transcription factor expression declines with age in differentiating cultured preadipocytes (18) . Others have also found that expression of CIEBPa declines with age in freshly isolated liver tissue (19) . The authors of the current study found that CIEBPa mRNA levels tended to decline in whole fat tissue with increasing age, confirming these earlier reports. We found declining differentiation-dependent CIEBPa mRNA expression with age in preadipocytes cultured from animals of different ages in parallel (18) . Furthermore, we found that transfecting preadipocytes from old animals with a CIEBPa vector restored the capacity of the cells to differentiate. This indicates that genes downstream of CIEBPa in the differentiation cascade retain their ability to respond to this transcription factor. We also found that the differentiation-dependent profile of CIEBPI3 mRNA expression did not change with age. This factor is upstream of PPAR-y and CIEBPa. The authors' suggestion that age-related changes in expression of specific genes occurs in fat tissue is in agreement with our finding that CIEBPI3 mRNA expression does not change. The authors' finding of reduced PPAR-y expression is consistent with the hypothesis that something happens after CIEBPI3 transcription and before CIEBPa expression during the transcription factor cascade.
The results of this study and our study on aging changes in CIEBPa and 13 expression in differentiating preadipocytes point to several avenues for further work. Among the first is the need to determine changes with age in expression and activity of PPAR-y and related molecules in pure populations of cells cultured from individualsof different ages. The decline in whole fat tissue PPAR-y expression found in this study underscores the importance of this next step. Associations between aging and ac-B189 Bl90 KIRKLAND tivityof these molecules resulting from such studies will need to be tested with pharmacological and molecularbiological manipulations.This area of work is important,becausea dissectionof the nature and causesof age-related changesin transcription factor regulationof differentiation will permit development of specificinterventions to improve tissuefunction.
